M. Antivalle

790 total citations
30 papers, 489 citations indexed

About

M. Antivalle is a scholar working on Rheumatology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, M. Antivalle has authored 30 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 8 papers in Cardiology and Cardiovascular Medicine and 6 papers in Epidemiology. Recurrent topics in M. Antivalle's work include Rheumatoid Arthritis Research and Therapies (9 papers), Inflammatory Bowel Disease (6 papers) and Blood Pressure and Hypertension Studies (6 papers). M. Antivalle is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (9 papers), Inflammatory Bowel Disease (6 papers) and Blood Pressure and Hypertension Studies (6 papers). M. Antivalle collaborates with scholars based in Italy and United States. M. Antivalle's co-authors include Piercarlo Sarzi‐Puttini, Fabiola Atzeni, Sandro Ardizzone, Ennio Giulio Favalli, Roberto Caporali, Alberto Batticciotto, Maria Chiara Ditto, M. Battellino, Donatella Ventura and Antonio Marchesoni and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and World Journal of Gastroenterology.

In The Last Decade

M. Antivalle

29 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Antivalle Italy 12 213 100 95 78 78 30 489
Samuele Naviglio Italy 15 119 0.6× 191 1.9× 126 1.3× 163 2.1× 102 1.3× 45 648
Luciana Parente Costa Seguro Brazil 14 289 1.4× 36 0.4× 106 1.1× 98 1.3× 80 1.0× 38 583
C. Belizna France 10 137 0.6× 37 0.4× 118 1.2× 64 0.8× 100 1.3× 26 470
Valentina De Angelis Italy 12 136 0.6× 44 0.4× 72 0.8× 24 0.3× 109 1.4× 45 407
Seong‐Ryul Kwon South Korea 14 254 1.2× 32 0.3× 95 1.0× 68 0.9× 36 0.5× 51 566
Emma Allain‐Launay France 12 62 0.3× 99 1.0× 135 1.4× 35 0.4× 90 1.2× 24 627
Estela Paz‐Artal Spain 15 45 0.2× 77 0.8× 272 2.9× 93 1.2× 39 0.5× 35 702
Deborah L. Yetman United States 7 179 0.8× 50 0.5× 262 2.8× 152 1.9× 99 1.3× 9 693
Arad Dotan Israel 8 48 0.2× 44 0.4× 80 0.8× 29 0.4× 77 1.0× 21 590
M Häusler Austria 13 80 0.4× 48 0.5× 47 0.5× 75 1.0× 51 0.7× 41 717

Countries citing papers authored by M. Antivalle

Since Specialization
Citations

This map shows the geographic impact of M. Antivalle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Antivalle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Antivalle more than expected).

Fields of papers citing papers by M. Antivalle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Antivalle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Antivalle. The network helps show where M. Antivalle may publish in the future.

Co-authorship network of co-authors of M. Antivalle

This figure shows the co-authorship network connecting the top 25 collaborators of M. Antivalle. A scholar is included among the top collaborators of M. Antivalle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Antivalle. M. Antivalle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ditto, Maria Chiara, Simone Parisi, Gian Paolo Caviglia, et al.. (2021). Intestinal microbiota changes induced by TNF-inhibitors in IBD-related spondyloarthritis. RMD Open. 7(3). e001755–e001755. 23 indexed citations
2.
Sarzi‐Puttini, Piercarlo, Daniela Marotto, M. Antivalle, et al.. (2020). How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion. Autoimmunity Reviews. 19(7). 102574–102574. 26 indexed citations
3.
Sarzi‐Puttini, Piercarlo, Donatella Ventura, M. Antivalle, et al.. (2020). What did COVID-19 do to the organization of Italian rheumatology? The examples of Luigi Sacco University Hospital and the Local Health district of ATS Sardegna: the two faces of the same coin. SHILAP Revista de lepidopterología. 2(1). 1–2.
4.
Talotta, Rossella, Sara Bongiovanni, Maria Chiara Ditto, et al.. (2019). Serum klotho concentrations inversely correlate with the severity of nailfold capillaroscopic patterns in patients with systemic sclerosis. Reumatismo. 71(1). 19–23. 2 indexed citations
5.
Cogliati, Chiara, M. Antivalle, Daniela Torzillo, et al.. (2014). Standard and pocket-size lung ultrasound devices can detect interstitial lung disease in rheumatoid arthritis patients. Lara D. Veeken. 53(8). 1497–1503. 71 indexed citations
6.
Caporali, Roberto, Serena Bugatti, Lorenzo Cavagna, et al.. (2013). WITHDRAWN: Abatacept as a first-line biological therapy. Autoimmunity Reviews. 1 indexed citations
7.
Atzeni, Fabiola, Maria Chiara Ditto, Alberto Batticciotto, et al.. (2013). Rheumatic manifestations in inflammatory bowel disease. Autoimmunity Reviews. 13(1). 20–23. 55 indexed citations
8.
Caporali, Roberto, Serena Bugatti, Lorenzo Cavagna, M. Antivalle, & Piercarlo Sarzi‐Puttini. (2013). Modulating the co-stimulatory signal for T cell activation in rheumatoid arthritis: Could it be the first step of the treatment?. Autoimmunity Reviews. 13(1). 49–53. 27 indexed citations
9.
Batticciotto, Alberto, V. Varisco, M. Antivalle, et al.. (2013). AB0297 Dose reduction in patients with rheumatoid arthritis responding to the standard rituximab regimen.. Annals of the Rheumatic Diseases. 72. A877–A877. 4 indexed citations
10.
Antivalle, M., Antonio Marchesoni, Ennio Giulio Favalli, et al.. (2011). Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN). Reumatismo. 60(4). 290–5. 25 indexed citations
11.
Atzeni, Fabiola, M. Antivalle, Francesca Bobbio‐Pallavicini, et al.. (2009). Predicting response to anti-TNF treatment in rheumatoid arthritis patients. Autoimmunity Reviews. 8(5). 431–437. 44 indexed citations
12.
Atzeni, Fabiola, et al.. (2009). Combined therapeutic approach: Inflammatory bowel diseases and peripheral or axial arthritis. World Journal of Gastroenterology. 15(20). 2469–2469. 18 indexed citations
13.
Sarzi‐Puttini, Piercarlo, Sandro Ardizzone, G. Manzionna, et al.. (2003). Infliximab-induced lupus in Crohn’s disease: a case report. Digestive and Liver Disease. 35(11). 814–817. 49 indexed citations
15.
Salvaggio, A., et al.. (1994). Blood pressure fluctuations, fractional integro-differentiation and spectral analysis. Medical & Biological Engineering & Computing. 32(S1). S86–S90. 1 indexed citations
16.
Mancia, Giuseppe, Gianfranco Parati, G. Pomidossi, et al.. (1987). Evaluation of the antihypertensive effect of once-a-day captopril by 24-hour ambulatory blood pressure monitoring. Journal of Hypertension. 5. 4 indexed citations
17.
Antivalle, M., et al.. (1987). Slow-Release Metoprolol and Nifedipine in Essential Hypertension. Journal of Cardiovascular Pharmacology. 10. S99–101. 1 indexed citations
18.
Antivalle, M., et al.. (1987). Slow-Release Metoprolol and Nifedipine in Essential Hypertension. Journal of Cardiovascular Pharmacology. 10. S99–101. 4 indexed citations
19.
Antivalle, M., et al.. (1986). Blood Pressure Levels in Adolescents: The Milan Study. Journal of Cardiovascular Pharmacology. 8(Supplement 5). S113–S115. 3 indexed citations
20.
Antivalle, M., et al.. (1985). Ambulatory blood pressure monitoring (24 h), basal blood pressure and left ventricular echocardiographic findings in young adults.. PubMed. 3(3). S339–41. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026